Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Reducing cardiovascular morbidity and mortality in the elderly.

P Trenkwalder¹

¹Department of Medicine, University of Munich, Starnberg Hospital, Germany.

Blood Pressure. Supplement

|November 4, 2000

Summary

The SCOPE trial investigated candesartan cilexetil for mild hypertension in elderly patients. This study assessed its impact on cardiovascular events and cognitive decline, offering insights into treating this population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension].

Der Internist·2019

Same author

Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension.

Blood pressure·2017

Same author

[Antihypertensive treatment after stroke: target blood pressure and treatment recommendations].

Deutsche medizinische Wochenschrift (1946)·2012

Same author

[High blood pressure in the morning].

MMW Fortschritte der Medizin·2012

Same author

[Acute stroke in hypertensive patients: treat hypertension slowly and check blood pressure continuously].

MMW Fortschritte der Medizin·2011

Same author

Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.

Blood pressure. Supplement·2009

Area of Science:

Cardiology
Geriatrics
Pharmacology

Background:

Elderly patients with mild hypertension face significant cardiovascular and cerebrovascular risks, including dementia.
Previous trials focused on moderate hypertension, leaving mild hypertension in the elderly understudied.
Effective blood pressure control is crucial for reducing morbidity and mortality in older adults.

Purpose of the Study:

To evaluate the efficacy of candesartan cilexetil in reducing major cardiovascular events in elderly patients with mild hypertension.
To determine the effect of candesartan cilexetil on preventing cognitive impairment in this demographic.
To assess the benefits of angiotensin II type 1 receptor blockers in protecting target organs.

Main Methods:

A prospective, randomized, double-blind, parallel comparison trial involving approximately 5000 elderly patients (70-89 years).
Patients received candesartan cilexetil (8 or 16 mg daily) or placebo for a mean follow-up of 2.5 years.
Mild hypertension defined as sitting systolic blood pressure of 160-179 mmHg and/or sitting diastolic blood pressure of 90-99 mmHg.

Main Results:

Candesartan cilexetil demonstrated high efficacy in lowering blood pressure.
Tolerability was comparable to placebo across various patient groups.
The study is designed to provide definitive evidence on cardiovascular and cerebrovascular benefits.

Conclusions:

Antihypertensive therapy with candesartan cilexetil is beneficial for elderly patients with mild hypertension.
This treatment may offer significant protection against cardiovascular and cerebrovascular events.
Angiotensin II type 1 receptor blockers may mitigate negative angiotensin II effects on target organs.

Related Experiment Videos